Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California
Preprint
- 25 August 2021
- preprint
- research article
- Published by Cold Spring Harbor Laboratory
Abstract
Associations between vaccine breakthrough cases and infection by SARS coronavirus 2 (SARS-CoV-2) variants have remained largely unexplored. Here we analyzed SARS-CoV-2 whole-genome sequences and viral loads from 1,373 persons with COVID-19 from the San Francisco Bay Area from February 1 to June 30, 2021, of which 125 (9.1%) were vaccine breakthrough infections. Fully vaccinated were more likely than unvaccinated persons to be infected by variants carrying mutations associated with decreased antibody neutralization (L452R, L452Q, E484K, and/or F490S) (78% versus 48%, p = 1.96e-08), but not by those associated with increased infectivity only (N501Y) (85% versus 77%, p = 0.092). Differences in viral loads were non-significant between unvaccinated and fully vaccinated persons overall (p = 0.99) and according to lineage (p = 0.09 – 0.78). Viral loads were significantly higher in symptomatic as compared to asymptomatic vaccine breakthrough cases (p < 0.0001), and symptomatic vaccine breakthrough infections had similar viral loads to unvaccinated infections (p = 0.64). In 5 cases with available longitudinal samples for serologic analyses, vaccine breakthrough infections were found to be associated with low or undetectable neutralizing antibody levels attributable to immunocompromised state or infection by an antibody-resistant lineage. Taken together, our results suggest that vaccine breakthrough infecions are overrepresnted by circulating antibody-resistant SARS-CoV-2 variants, and that symptomatic breakthrough infections may potentially transmit COVID-19 as efficiently as unvaccinated infections, regardless of the infecting lineage.Keywords
Other Versions
- Published version: Version Nature Microbiology, 7, preprints
This publication has 28 references indexed in Scilit:
- Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, BrazilScience, 2021
- Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variantCell, 2021
- Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individualsPublished by Cold Spring Harbor Laboratory ,2021
- COVID-19 vaccine impact on rates of SARS-CoV-2 cases and post vaccination strain sequences among healthcare workers at an urban academic medical center: a prospective cohort studyPublished by Cold Spring Harbor Laboratory ,2021
- Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United StatesCell, 2021
- Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccineNature Medicine, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineThe New England Journal of Medicine, 2021
- Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern CaliforniaScience, 2020
- A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiologyNature Microbiology, 2020
- Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samplesNature Protocols, 2017